NASDAQ: MAZEMaze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?
Insider buying vs selling
Have Maze Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when MAZE insiders and whales buy or sell their stock.
MAZE Shareholders
What type of owners hold Maze Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Third Rock Ventures IV LP | 16.04% | 7,024,758 | $94.13M | Insider |
| Trv GP IV LLC | 13.87% | 6,073,958 | $81.39M | Institution |
| Frazier Life Sciences Management LP | 9.43% | 4,129,001 | $55.33M | Institution |
| Arch Venture Management LLC | 9.41% | 4,120,053 | $55.21M | Institution |
| Deep Track Capital LP | 7.46% | 3,269,126 | $43.81M | Institution |
| Matrix Capital Management Company LP | 5.68% | 2,486,184 | $33.31M | Institution |
| Alphabet Inc | 5.51% | 2,412,471 | $32.33M | Institution |
| Foresite Capital Management IV LLC | 4.82% | 2,111,919 | $28.30M | Institution |
| Ah Capital Management LLC | 3.89% | 1,702,225 | $22.81M | Institution |
| Janus Henderson Group PLC | 2.85% | 1,246,370 | $16.70M | Institution |
MAZE vs Biotech Stocks
Maze Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.